Commercial Satellite Imaging Market by Transparency Market Research

525928_357561407618243_2064896067_nAccording to a new market report “Commercial Satellite Imaging Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2013 – 2019” published by Transparency Market Research, the market for commercial satellite imaging globally is forecast to reach USD 5,018.6 million by 2019. The market growth is driven by increased demand for applications such as oil and gas (energy) sector management and natural resource management. Insurance, real estate and city planning and fleet management are emerging as potential commercial applications for satellite imagery market.

Browse the full report with TOC: http://www.transparencymarketresearch.com/commercial-satellite-imaging-market.html

Globally, this market was valued at USD 2,054.5 million in 2012 and is forecast to grow at 13.9% CAGR from 2013 – 2019. The data collected by satellites images has commercial value across industries, including commercial enterprises, civil engineering, military, forestry & agriculture, energy sectors and insurance, among others. Global commercial satellite imaging market in 2012 was dominated by the military segment, which accounted for 29.2% revenue share. It is due to quick adoption of this technology by major countries particularly in the defense sector, where high resolution satellite imagery is being implemented to develop their security programs and bolster vigilance systems.

This technology is mainly used in the energy sector, geospatial technology, natural resources management, construction & development, media & entertainment disaster response management, defense & intelligence and conservation & research among others. Geospatial technology, energy and natural resource management are emerging as promising applications for satellite imaging industry. These three segments together accounted for approximately 41.8% of market revenue share in 2012. Governments purchase commercial satellite imagery in order to support national security reconnaissance activities, climate change research, weather prediction, and land management activities. Growth of the commercial satellite imagery is driven by increasing demand from defense sector, predominantly by countries with large imagery intelligence (IMINT) requirements. Currently, due to rising terrorism concerns, defense and intelligence departments all over the world are seeking ways to support their security initiatives using satellite imagery.

Geographically, North America is expected to remain largest market for commercial satellite imagery followed by Europe. North America and Europe collective had revenue share of 70.7% in 2012. Commercial satellite imagery market in North America has been world-leading, and is expected to dominate the global market during the forecast period in spite of reduction in government funding. Europe is showing slower growth due to lower economic activity and turbulent budgetary situation, due to which large finance activities have been withheld or suspended for short term.

Browse full PDF with TOC: Commercial Satellite Imaging Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2013 – 2019

Market participants include renowned companies such as Digital Globe Inc., GeoEye Inc., Astrium Geo, who are currently dominating the market space. GeoEye and DigitalGlobe represented approximately 65.1% of commercial satellite imagery market in 2012. New participants are expected to face stiff competition from existing players, and will have to focus on service differentiation and quality, so as to sustain growth in the long run. Other players in the market include ImageSat International N.V., BlackBridge (RapidEye) and Skybox Imaging, Inc. among others.

This report analyzes the global commercial satellite imaging market in terms of revenue (USD million). The market has been segmented as follows:

Commercial Satellite Imaging Market, by Industry Vertical:

  • Government
  • Commercial enterprises
  • Civil engineering industry
  • Military
  • Forestry and agriculture
  • Energy sectors
  • Insurance

Commercial Satellite Imaging Market, by Application:

  • Energy
  • Geospatial technology
  •  Natural resources management
  • Construction and development
  • Disaster response management
  • Defense and intelligence
  • Conservation & research
  • Media and entertainment

Commercial Satellite Imaging Market, By Geography:

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)
Advertisements

Global Caprolactam Market New Published Report by Transparency Market Research

Transparency Market ResearchTransparency Market Research has released a new market report titled “Caprolactam (Nylon 6 Fiber and Nylon 6 Resin) Market For Textiles, Carpets, Industrial Yarns, Engineering Plastics, Packaging, Electronics and Other Applications – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 – 2019,” which observes that the caprolactam demand in 2012 was worth USD 8.66 billion and is expected to reach USD 13.80 billion by 2019, growing at a CAGR of 6.9% from 2013 to 2019. In terms of volume, the demand for caprolactam was 3,580.0 kilo tons in 2012.

Browse the full Report with TOC: http://www.transparencymarketresearch.com/caprolactam-market.html

Caprolactam is an important polymer having host of applications across different industries. Caprolactam is the key raw material for nylon 6. Caprolactam is used to produce nylon 6 fibers and resins that are used extensively in various applications. The growing demand of nylon 6 in engineering and automobile applications as well as rapid economic growth in Asia Pacific is expected to remain the major driving force for the caprolactam market. Volatile raw material prices are expected to be a key challenge for market participants.

Nylon 6 fibers dominated the consumption of caprolactam and accounted for over 66% of total demand in 2012. Superior chemical as well as physical characteristics such as light weight and high tensile strength, nylon 6 fibers have become materials of choice in various textile and carpets application. The use of caprolactam in nylon 6 resin production employed in engineering plastics and electronic applications is anticipated to be the major growth market over the next few years. Similar surge in demand is expected to be witnessed from industrial yarn applications where nylon 6 fibers are used as tire cords for enhanced wear resistance and high strength characteristics.

Asia Pacific accounted for about 51% of the total caprolactam market in 2012, followed by Europe and North America. Asia Pacific is also expected to be the fastest growing regional market in terms of both caprolactam consumption and production. This can be attributed to the growing economies in this region. Skilled labor, cheap availability of raw materials, equipments, and land has resulted in Asia Pacific emerging as a key destination for caprolactam producers. Recently various manufacturers have concentrated on capacity expansion in Asia Pacific to increase their production capacities. Europe is the other major region where caprolactam consumption was very strong and is expected to grow in demand with a CAGR of about 6.4% in terms of volume from 2013 and 2019.

DSM, BASF SE, Honeywell, Ube Industries and Capro Corporation are some of the major participants in the caprolactam industry.

Browse full PDF with TOC: Caprolactam Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 – 2019

Caprolactam Market – Product Segment Analysis

  • Nylon 6 fiber
  • Nylon 6 resin

Caprolactam Market – Application Segment Analysis

  • Nylon 6 fiber
  • Textiles
  • Carpet
  • Industrial yarns
  • Others (fishing lines, fishing nets, bristles, surgical suture, etc.)
  • Nylon 6 resin
  • Engineering plastic
  • Packaging
  • Electronics
  • Others (musical strings, composites, lysine synthesis, etc.)

Caprolactam Market – Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World (RoW)

Browse more market research reports: Transparency Market Research

Ophthalmic Drugs Market is Expected to Reach USD 21.6 Billion Globally in 2018: Transparency Market Research

Ophthalmic Drugs MarketAccording to a new market report published by Transparency Market Research “Ophthalmic Drugs Market (Dry eye, Anti-glaucoma, Anti allergy/ inflammatory/ infective, Retinal Drugs) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2018” the global ophthalmic drugs market was valued at USD 16 billion in 2012 and is expected to grow at a CAGR of 5.2% from 2013 to 2018, to reach an estimated value of USD 21.6 billion in 2018.

Browse the full Report with TOC: http://www.transparencymarketresearch.com/ophthalmic-drugs-market.html

Globally, the ophthalmic drugs market is witnessing significant growth due to increasing prevalence of eye disorders such as diabetic retinopathy and macular degeneration. As a result, this market is expected to grow at a CAGR of about 5.2% during 2013 – 2018.

Some of the key driving factors for the ophthalmic drugs market are rising prevalence of global aging population, increasing government initiatives towards healthcare infrastructure in developing countries (such as India and China), technological changes in drug delivery technique, and increasing prevalence of lifestyle associated diseases. However, the market faces some restraints such as lack of awareness among people regarding eye disorders, drying pipeline of ophthalmic drugs, patent expiration of blockbuster ophthalmic drugs and absence of health insurance in developing countries.

download-pdf

North America, including the US has the largest ophthalmic drugs market. Asia is the fastest growing ophthalmic drugs market. Some of the fastest growing markets for ophthalmic drugs are China, India, other countries in South East Asia and the Eastern Mediterranean. As per WHO estimates in 2010, in the next nine years, the number of blind people aged 50 years and above will grow in these regions, thereby increasing the demand for ophthalmic drugs. On the other hand, in developed regions such as North America and Western Europe, rising efforts towards prevention of blindness among the aging population has emerged as a key driver for the market.

Browse full PDF with TOC: Ophthalmic Drugs Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2018

Glaucoma has the largest market share in the ophthalmic drugs market and it is expected to grow at a CAGR of about 4.2% during 2013 – 2018. Various ophthalmic drug companies are increasing their focus on combination therapy, which involves use of more than one medication for specific retinal disorders. Most of these combination therapies are used as first line treatment in patients with high level of intraocular pressure. Combination therapy has various advantages over traditional medication such as reduced frequency of eye drop application, improved patient compliance and efficacy.

Novartis (Alcon) is the leading player in the global ophthalmic drugs market while other major players include Allergan, Santen, Pfizer, Merck and Roche.

The global ophthalmic drugs market is segmented as follows:

Ophthalmic Drugs Market, By Treatment Drugs

  • Dry Eye Drugs
  • Retinal Drugs
  • Anti-inflammatory/allergy/infective Drugs
  • Anti-glaucoma Drugs

Ophthalmic Drugs Market, By Types

  • Prescription Drugs
  • OTC Drugs

Ophthalmic Drugs Market, by Geography

  • North America
  • US
  • Europe
  • Germany
  • UK
  • France
  • Asia Pacific
  • Japan
  • China
  • India
  • Rest of the World (RoW)

Browse more market research reports: Transparency Market Research

Global 3D ICs Market by Transparency Market Research

polyurethane and polyolsAccording to a new market report “3D ICs (MEMS and sensors, RF SiP, Optoelectronics and imaging, Memories, Logic, HB LED) Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2013 – 2019” published by Transparency Market Research, the market for 3D ICs globally is forecast to reach USD 7.52 billion by 2019. The market growth is expected to be driven by increased demand for devices with exceptional speed, low power consumption, smaller chip size, and reduced response time. Information and communication technology (ICT) and consumer electronics are seen as emerging sectors for adoption of 3D ICs and are expected to support the market growth during the forecast period 2013 – 2019.

Browse the full report with TOC: http://www.transparencymarketresearch.com/3d-ics-market.html

Globally, 3D ICs market was valued at USD 2.40 billion in 2012 and is forecast to grow at 18.1% CAGR from 2013 – 2019. Different end-use industry sectors such as consumer electronics, ICT, transport (automotive and aerospace), military and others (biomedical applications and R&D), are getting benefitted by 3D IC integration technology. The global 3D ICs market in 2012 was dominated by the ICT sector, which accounted for 24.2% revenue share. The bandwidth requirement for high performance networking equipment and storage capacity of devices rises in every new generation. Hence, to address bandwidth and memory challenges emerging ICT sector is expected to adopt 3D IC integration technology for its high chip density and high bandwidth advantages. SOI (silicon on insulator) wafers are widely preferred for 3D IC fabrication as it reduces unwanted heat production and parasitic capacitance.

Various industry products such as MEMS and sensors, optoelectronics and imaging, RF SiP, memories, logic (3D SiP/SoC) and HB LED are expected to deploy 3D IC integration. Among these products MEMS and sensor, logic (3D SiP/SoC) and memories (3D Stacks) together accounted for approximately 67.6% of market revenue share in 2012. Continuous demand for devices with less expensive storage and higher capacity are the key factors for driving NAND and DRAM memory market. With the increasing demand for consumer electronic products, sales of image sensor and MEMS devices are estimated to grow in the forecast period. This in turn is expected to support adoption of 3D ICs in various devices. Geographically, Asia Pacific is expected to remain largest market for 3D IC technology due to the emerging ICT and consumer electronics sector in this region. Asia Pacific’s revenue share in 2012 was 40.7%.

Driven by emerging opportunities and high growth potential, various players from semiconductors and packaging are entering 3D IC integration space, making the competition intense. Among these, players such as Taiwan Semiconductor Manufacturing Company Ltd. (TSMC), Xilinx Inc., Samsung Electronics Co. Ltd., have dominant position in the market, collectively accounting for more than 54.5% of the market in 2012, with TSMC being the leader. New entrants are expected to face stiff competition from existing players, and will have to focus on high investments on R&D and comprehensive ecosystem for IC integration and testing so as to sustain growth in the long run. Other vendors in the market are: 3M Company, Micron Technology Inc., (Elpida Memory Inc.), Ziptronix, Inc., MonolithIC 3D Inc., TEZZARON Semiconductor, STATS ChipPAC Ltd. and United Microelectronics Corporation (UMC) among others.

This report analyzes the global 3D ICs market in terms of revenue (USD million). The market has been segmented as follows:

Browse full PDF with TOC: 3D ICs Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2013 – 2019

3D ICs Market, By Product:

  • MEMS and Sensor
  • RF SiP
  • Optoelectronics and imaging
  • Memories (3D Stacks)
  • Logic (3D Sip/Soc)
  • HB LED

3D ICs Market, By End-Use Sectors:

  • Consumer electronics
  • Information and communication technology
  • Transport (automotive and aerospace)
  • Military
  • Others(Biomedical applications and R&D)

3D ICs Market, By Substrate Type:

  • Silicon on insulator(SOI)
  • Bulk Silicon

3D ICs Market, By Fabrication Process:

  • Beam re-crystallization
  • Wafer bonding
  • Silicon epitaxial growth
  • Solid phase crystallization

3D ICs Market, By Geography:

  • North America
  • Europe
  • Asia Pacific
  • Rest of World (RoW)

Hospital Acquired Disease Testing Market Expected to Reach USD 7.5 Billion Globally in 2019: Transparency Market Research

Medical_Devices copyAccording to a new market report published by Transparency Market Research “Hospital Acquired Disease Testing Market (Pneumonia, UTI, Blood Stream, Surgical Site, MRSA Infection, and Others) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019”, the global hospital acquired disease testing market was valued at USD 2.2 billionin 2012 and is expected to grow at a CAGR of 19.3% from 2013 to 2019, to reach an estimated value of USD 7.5 billion in 2019.

Browse the full report with TOC: http://www.transparencymarketresearch.com/hospital-acquired-disease-testing.html

Nosocomial infections/hospital acquired diseases/hospital associated infections (HAI)form one of the critical areas of focus in the healthcare industry. Factors such as increasing prevalence of such conditions in neonatal and geriatric population, initiatives taken up by governments to manage nosocomial infections, increasing number of diseases that increases risk of hospital associated infections, and growing concerns about control and prevention of nosocomial infections worldwide will have a positive impact on the current hospital acquired disease testing industry.

The global hospital acquired disease testing market is segmented on the basis of type of infection and geography. Based on the different typesof infection,this market is classified into pneumonia, urinary tract infection, blood stream infection, surgical site associated infection, MRSA infection testing and others. The hospital acquired urinary tract infection diagnostics segment occupies the largest market share in this category as prevalence and morbidity rate of this condition, and the demand for diagnostic solutions for the same is the highest as compared to other hospital associated infections. It is expected that the global market for hospital associated urinary tract infection testing will reach USD 2,188.8 million in 2019 with the market growing at CAGR of 18.1%from 2013 to 2019. Furthermore, other testing solutions for conditions such as surgical site infections and pneumonia (hospital associated and ventilator associated infections) will also experience high demand in lesser developed regions of Asia-Pacific, Latin America and other developing countries where the prevalence of such conditions is higher. It is expected that the market for surgical site infections will grow at a CAGR of 20.1%during the given period of forecast.

Geographically, United States and Canada together are the leaders in the global hospital acquired disease testing market with a combined market share (of the North American region) of 41.3% in 2012. Some of the major growth drivers for the North American nosocomial infection testing market include existence of highly developed healthcare infrastructure, high rate of implementation of healthcare guidelines given by regulatory and guiding institutions such as Centers for Disease Control and Prevention (U.S.), and increasing awareness about these diseases and their prevention. The European Union considers infectious diseases as an increasing threat to the general public health; the public health system in this region is increasingly engaging itself in conducting dialogue between healthcare providers and medical practitioners for developing better, faster and cost effective methods for nosocomial infection management and prevention. Asian countries including China, Philippines and India are the most potential markets for such diagnostic and testing solutions owing to existence of factors such as higher population, poor hospital infrastructure, lack of adherence to sanitation procedures and therefor higher disease prevalence growth rates. UAE and African countries are some of the lucrative markets in the Rest of the World (RoW).

Browse full PDF with TOC: Hospital Acquired Disease Testing Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

Molecular diagnostics solutions play a vital role in this market as they offer precise, faster and cost effective diagnosis for various nosocomial infections. Considering the market competition, the global hospital acquired infection testing market is highly fragmented and is characterized by the existence of several large and mid-sized diagnostic solution providers. Some of the key market players contributing to this industry include Diatherix Laboratories Inc., Gen-Probe Inc., Qiagen GmbH, L Hoffman La Roche,Cepheid, Inc.,Life Technologies Corporation, Meridian Biosciences, Cantel Medical Corporation, Nordion, Inc. and others.

The global hospital acquired disease testing market is segmented as follows:

Hospital Acquired Disease Testing Market, by Infection Type

  • Pneumonia infection
  • Urinary tract infection
  • Blood stream associated infection
  • Surgical site infection
  • MRSA infection

Hospital Acquired Disease Testing Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World